These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3065723)

  • 21. [Insulin therapy using a new injection device. Experience with 36 type I diabetics].
    Stracke H; Federlin K
    Dtsch Med Wochenschr; 1987 Mar; 112(10):385-8. PubMed ID: 3545743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.
    Buysschaert M; Minette P; Ketelslegers JM; Pairet JV; Vogels M; Lambert AE
    Diabetes Res; 1987 Jan; 4(1):31-3. PubMed ID: 3552364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multiple injection regimen using an insulin injection pen and pre-filled cartridged soluble human insulin in adolescents with diabetes.
    Jefferson IG; Marteau TM; Smith MA; Baum JD
    Diabet Med; 1985 Nov; 2(6):493-5. PubMed ID: 2951125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST).
    Rom J Intern Med; 1997; 35(1-4):99-113. PubMed ID: 9562659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Sommavilla B; Pietranera G
    J Diabetes Sci Technol; 2011 Sep; 5(5):1212-21. PubMed ID: 22027321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen-injector.
    Hardy KJ; Jones KE; Gill GV
    Diabet Med; 1991 Jan; 8(1):69-71. PubMed ID: 1826248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.
    Dorchy H; Duchateau J; D'Hooge D
    Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The metabolic and psychological assessment of 40 adolescents with type-1 diabetes during 6 months of intensified insulin therapy using the pen injector or the traditional syringe].
    Cherubini V; Guazzarotti L; Bartolotta E
    Pediatr Med Chir; 1991; 13(1):67-71. PubMed ID: 2052459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pen injector for insulin-requiring diabetic patients.
    Hung CT; Wang FF
    J Formos Med Assoc; 1992 Oct; 91(10):1026-9. PubMed ID: 1362671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with functional insulin therapy: metabolic follow up and patient cooperation].
    Fövényi J; Szövérffy G; Thaisz E; Lehotkai L
    Orv Hetil; 1991 Sep; 132(36):1963-7. PubMed ID: 1923467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control with different premixed insulin in Taiwanese people with type two diabetes mellitus.
    Su CC; Chen HS; Lin HD
    J Chin Med Assoc; 2003 Mar; 66(3):155-9. PubMed ID: 12779035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.
    Kadiri A; Chraibi A; Marouan F; Ababou MR; el Guermai N; Wadjinny A; Kerfati A; Douiri M; Bensouda JD; Belkhadir J; Arvanitis Y
    Diabetes Res Clin Pract; 1998 Jul; 41(1):15-23. PubMed ID: 9768368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic-bolus therapy of diabetic children and adolescents using Novo Pens].
    Schober E; Borkenstein M; Frisch H
    Wien Klin Wochenschr; 1987 May; 99(9):312-3. PubMed ID: 3300042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Basal bolus therapy in adolescent diabetic patients].
    Steinemann MA; Zuppinger K
    Ther Umsch; 1990 Jan; 47(1):22-9. PubMed ID: 2408179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and acceptance of two intensified conventional insulin therapy regimens: a long-term cross-over comparison.
    Houtzagers CM; Berntzen PA; van der Stap H; van Maarschalkerweerd WW; Lanting P; Boen-Tan I; Heine RJ; van der Veen EA
    Diabet Med; 1989 Jul; 6(5):416-21. PubMed ID: 2527678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy.
    Martina V; Tagliabue M; Maccario M; D'Antona G; Camanni F
    Diabete Metab; 1989; 15(6):372-4. PubMed ID: 2697606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety performance of the Innovo insulin doser.
    Valk NK; Cerny G; Sieber J; Lytzen L; Berg B
    Diabetes Technol Ther; 2004 Feb; 6(1):53-8. PubMed ID: 15000770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.
    Nielsen FS; Jørgensen LN; Ipsen M; Voldsgaard AI; Parving HH
    Diabetologia; 1995 May; 38(5):592-8. PubMed ID: 7489843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of diabetes and quality of life. On possibilities of a more normalized life style using an insulin pen for multi-injection therapy].
    Andresen IL; Haug J; Jervell J; Paus PN
    Tidsskr Nor Laegeforen; 1989 Feb; 109(6):677-80. PubMed ID: 2646754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.